Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Mar 2024 16:40

RNS Number : 1157H
Indivior PLC
15 March 2024

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on March 14, 2024, that Cindy Cetani, a PDMR, sold a total of 66,073 ordinary shares of US$0.50 each in the Company ('Shares') on March 14, 2024 at an average price of £16.21 per Share.

Following this transaction, Cindy has a beneficial interest in 121,737 Shares in the Company.

Further information is provided below in accordance with the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Cindy Cetani

2

Reason for the notification

a)

Position/status

PDMR - Chief Integrity and Compliance Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Indivior PLC

b)

LEI

213800V3NCQTY7IED471

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of US$0.50

GB00BN4HT335

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£16.21

66,073

d)

Aggregated information

- Volume

- Price

- Total

n/a

e)

Date of the transaction

March 14, 2024

f)

Place of the transaction

London Stock Exchange (XLON)

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGPUBWWUPCGQA
Date   Source Headline
27th Jul 20177:00 amRNSHalf Year Financial Results
13th Jul 20172:00 pmRNSNotice of Results
29th Jun 201711:00 amRNSRBP-6000 Investor Event Reminder
16th Jun 20172:00 pmRNSRBP-6000 Investor Event
2nd Jun 20179:25 amRNSBlock Listing Six Monthly Return
1st Jun 20173:16 pmRNSTotal Voting Rights
30th May 20174:24 pmRNSRBP-6000 - Submission of NDA to U.S. FDA
23rd May 20175:00 pmRNSJefferies Global Healthcare Conference
17th May 20175:36 pmRNSResult of AGM
10th May 20174:04 pmRNSBlock Listing Six Monthly Return
3rd May 201712:00 pmRNS1st Quarter Results
19th Apr 20172:00 pmRNSNotice of Results
7th Apr 20179:58 amRNSHolding(s) in Company
28th Mar 20172:00 pmRNSAdditional RBP-6000 Clinical Study Results
23rd Mar 20171:00 pmRNSAnnual Financial Report
13th Mar 201712:00 pmRNSTop-line Phase 3 Trial Results - RBP-7000
7th Mar 20175:29 pmRNSDirector Resignation
27th Feb 20171:50 pmRNSDirector/PDMR Shareholding
27th Feb 20171:22 pmRNSDirector/PDMR Shareholding
22nd Feb 20177:00 amRNSDirectorate Change
22nd Feb 20177:00 amRNSFull Year Financial Results
15th Feb 20175:04 pmRNSDirector Declaration
14th Feb 20174:19 pmRNSHolding(s) in Company
13th Feb 20177:00 amRNSHolding(s) in Company
10th Feb 20174:48 pmRNSHolding(s) in Company
9th Feb 20179:56 amRNSHolding(s) in Company
6th Feb 201712:00 pmRNSNotice of Results
3rd Feb 20171:30 pmRNSDirector Declaration
1st Feb 20177:00 amRNSTotal Voting Rights
24th Jan 20171:00 pmRNSDirectorate Change
9th Jan 20171:00 pmRNSJP Morgan Healthcare Conference
23rd Dec 20169:21 amRNSHolding(s) in Company
9th Dec 201612:55 pmRNSResearch & Development Day in New York
28th Nov 20161:53 pmRNSAdditional Listing
10th Nov 20163:54 pmRNSBlock Listing Six Monthly Return
2nd Nov 201612:00 pmRNS3rd Quarter Results
27th Oct 20164:53 pmRNSNotice of Results
3rd Oct 20162:00 pmRNSDirectorate Change
3rd Oct 20169:17 amRNSHolding(s) in Company
27th Sep 20167:00 amRNSState Attorneys General Complaint Filed
23rd Sep 20167:00 amRNSCivil Complaint Filed by State Attorneys General
1st Sep 20162:22 pmRNSAppointment Update
17th Aug 20167:00 amRNSTop-line Phase 3 Pivotal Study Results - RBP-6000
16th Aug 20162:19 pmRNSDirector Declaration
12th Aug 201610:45 amRNSDirector/PDMR Shareholding
3rd Aug 201610:05 amRNSDirector/PDMR Shareholding
2nd Aug 20163:05 pmRNSDirector/PDMR Shareholding
29th Jul 20167:00 amRNSHalf Year Financial Results
15th Jul 20167:00 amRNSIntention to List ADRs in U.S.
12th Jul 20162:00 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.